BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8860606)

  • 1. In vitro evaluation of polymeric matrix and porous biodegradable reservoir devices for slow-release drug delivery.
    Peyman GA; Yang D; Khoobehi B; Rahimy MH; Chin SY
    Ophthalmic Surg Lasers; 1996 May; 27(5):384-91. PubMed ID: 8860606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release of ganciclovir and foscarnet from biodegradable scleral plugs for the treatment of cytomegalovirus retinitis.
    Peng YJ; Wen CW; Chiou SH; Liu SJ
    Biomaterials; 2010 Mar; 31(7):1773-9. PubMed ID: 19969344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained local drug delivery from a radiopaque implanted reservoir.
    Koole LH; Kruft MA; Aldenhoff YB; van 't Oost NE; van Kroonenburgh MJ; van der Veen FH
    Nat Biotechnol; 1998 Feb; 16(2):172-6. PubMed ID: 9487525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysulfone capillary fiber for intraocular drug delivery: in vitro and in vivo evaluations.
    Rahimy MH; Peyman GA; Chin SY; Golshani R; Aras C; Borhani H; Thompson H
    J Drug Target; 1994; 2(4):289-98. PubMed ID: 7858954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits.
    López-Cortés LF; Pastor-Ramos MT; Ruiz-Valderas R; Cordero E; Uceda-Montañés A; Claro-Cala CM; Lucero-Muñoz MJ
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1024-8. PubMed ID: 11274081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS.
    Duker JS; Robinson M; Anand R; Ashton P
    Ophthalmic Surg Lasers; 1995; 26(5):442-8. PubMed ID: 8963859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new vitreal drug delivery system using an implantable biodegradable polymeric device.
    Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil.
    Khang G; Kim SW; Cho JC; Rhee JM; Yoon SC; Lee HB
    Biomed Mater Eng; 2001; 11(2):89-103. PubMed ID: 11352116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding.
    Vaz CM; van Doeveren PF; Dias GR; Reis RL; Cunha AM
    Macromol Biosci; 2004 Aug; 4(8):795-801. PubMed ID: 15468273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of ganciclovir in the human retina.
    Park SS; Girard B; Font RL; Hauw JJ; Young LH
    Curr Eye Res; 1998 Jun; 17(6):663-7. PubMed ID: 9663857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable microparticles and fiber fabrics for sustained delivery of cisplatin to treat C6 glioma in vitro.
    Xie J; Tan RS; Wang CH
    J Biomed Mater Res A; 2008 Jun; 85(4):897-908. PubMed ID: 17896769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ganciclovir on the hydrolytic degradation of poly(lactide-co-glycolide) microspheres.
    Chen X; Ooi CP; Lim TH
    J Biomater Appl; 2006 Jan; 20(3):287-302. PubMed ID: 16364967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular sustained drug delivery using implantable polymeric devices.
    Yasukawa T; Ogura Y; Sakurai E; Tabata Y; Kimura H
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2033-46. PubMed ID: 16263193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-encased polymer millirods for sustained release of 5-fluorouracil.
    Qian F; Nasongkla N; Gao J
    J Biomed Mater Res; 2002 Aug; 61(2):203-11. PubMed ID: 12007200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma.
    Roullin VG; Lemaire L; Venier-Julienne MC; Faisant N; Franconi F; Benoit JP
    Anticancer Res; 2003; 23(1A):21-5. PubMed ID: 12680190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term release of fluocinolone acetonide using biodegradable fumarate-based polymers.
    Haesslein A; Ueda H; Hacker MC; Jo S; Ammon DM; Borazjani RN; Kunzler JF; Salamone JC; Mikos AG
    J Control Release; 2006 Aug; 114(2):251-60. PubMed ID: 16872709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery.
    Wang C; He C; Tong Z; Liu X; Ren B; Zeng F
    Int J Pharm; 2006 Feb; 308(1-2):160-7. PubMed ID: 16359836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: Drug release, microstructure, and ex vivo permeation behaviors.
    Lei L; Liu X; Guo S; Tang M; Cheng L; Tian L
    J Control Release; 2010 Aug; 146(1):45-53. PubMed ID: 20566400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.